King Pharmaceuticals KG Diversified Legacy Segment — Net premiums written

Other segment segments

Legacy Reinsurance

$2.65M—

AmTrust Legacy Segment

$1.88M—

Similar metrics at other companies

EGLegacy — Net written premiums

$89M-83.9%

EGLegacy — Premiums Written, Gross

$135M-80.3%

SIGIInvestments Segment — Net premiums written

$0—

SPNTInsurance & Services — Net premiums written

$412.55M+33.5%

CNALife & Group — Net written premiums

$104.75M-2.6%

PGRPersonal Lines Segment — Net premiums written

$18.14B+14.3%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsWrittenNet.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's diversified legacy segment — net premiums written.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's diversified legacy segment — net premiums written?: King Pharmaceuticals (KG) reported diversified legacy segment — net premiums written of $775K in Q1 2026.
What does diversified legacy segment — net premiums written mean?: This metric represents the total premiums written by the Diversified Legacy Segment during a specific period, net of reinsurance ceded. It measures the volume of new and renewal business underwritten by this segment before accounting for the timing of revenue recognition. This figure serves as a key indicator of the segment's market reach and underwriting activity within its specific legacy insurance portfolio.